You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

December 6, 2017

Webinar: Thomas Treutler to Speak on Regulatory Developments in Vietnam and Thailand

Lifesciences Asia-Pacific Network

Partner Thomas J. Treutler will provide an update on the latest developments in the life sciences and healthcare sector in Vietnam and Thailand at a webinar organized by CMS and the Lifesciences Asia-Pacific Network (LAN). The webinar will be held on December 11 at 4 p.m. (Thailand/Vietnam time) and participation is free of charge. For more information and to register for the webinar, please visit the CMS website.

LAN is an international network of law firms specializing in advising pharma, biotech, and medtech companies to help clients to protect their innovations, capitalize on their investments, and manage their risks. By bringing together leading firms from across the Asia-Pacific region, LAN provides high-quality services to meet client needs while delivering commercially valuable local insights. Tilleke & Gibbins is the member firm for Thailand, Vietnam, Cambodia, Laos, and Myanmar.

RELATED INSIGHTS​ 

February 1, 2017
Tilleke & Gibbins has been nominated for the Thailand Law Firm of the Year Award 2017 by Chambers Asia-Pacific. The firm has been nominated for the award six times since 2010, and was honored to win the Thailand Law Firm of the Year Award 2014. This year’s winner will be announced at Chambers Asia-Pacific’s annual ceremony and dinner, which will be held at The Fullerton Hotel in Singapore on March 24, 2017.
October 13, 2016
Tilleke & Gibbins, together with EuroCham Vietnam, will hold a seminar focusing on legal issues in the pharmaceutical sector. The seminar will feature a panel of pharmaceutical and intellectual property experts from Japan, Thailand, and Vietnam, and it will provide attendees with an in-depth look at emerging issues in Vietnam’s rapidly developing pharmaceutical sector, including: